Brainsway (BRSYF) Total Debt (2018 - 2023)

Brainsway's (BRSYF) quarterly Total Debt came in at $106000.0 in Q3 2023, up 3.92% quarter-over-quarter from $102000.0 in Q2 2023.

Analysis

Brainsway (BRSYF) Total Debt (2018 - 2023) Analysis & Trends

Brainsway (BRSYF) has reported Total Debt for 3 consecutive years, with $106000.0 the latest figure, recorded in Q3 2023.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Total Debt (Qtr)
1	Abbott Laboratories	181.16 Bn	175.56 Bn	7.27 Bn	32.61 Bn
2	Intuitive Surgical	127.68 Bn	122.46 Bn	1.96 Bn	-
3	Medtronic	117.10 Bn	108.28 Bn	6.34 Bn	28.15 Bn
4	Stryker	104.81 Bn	101.33 Bn	4.50 Bn	14.94 Bn
5	Boston Scientific	64.48 Bn	63.94 Bn	3.85 Bn	12.62 Bn
6	Edwards Lifesciences	49.94 Bn	45.69 Bn	1.35 Bn	598.70 Mn
7	Alcon	33.07 Bn	31.61 Bn	1.68 Bn	4.15 Bn
8	Dexcom	32.37 Bn	30.42 Bn	830.00 Mn	-
9	Steris	20.77 Bn	20.28 Bn	684.20 Mn	2.14 Bn
10	Brainsway	592.58 Mn	529.41 Mn	12.77 Mn	-

Historic Data

Download Data